274 related articles for article (PubMed ID: 26221755)
1. Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.
Rabasco C; Cavero T; Román E; Rojas-Rivera J; Olea T; Espinosa M; Cabello V; Fernández-Juarez G; González F; Ávila A; Baltar JM; Díaz M; Alegre R; Elías S; Antón M; Frutos MA; Pobes A; Blasco M; Martín F; Bernis C; Macías M; Barroso S; de Lorenzo A; Ariceta G; López-Mendoza M; Rivas B; López-Revuelta K; Campistol JM; Mendizábal S; de Córdoba SR; Praga M;
Kidney Int; 2015 Nov; 88(5):1153-60. PubMed ID: 26221755
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series.
Avasare RS; Canetta PA; Bomback AS; Marasa M; Caliskan Y; Ozluk Y; Li Y; Gharavi AG; Appel GB
Clin J Am Soc Nephrol; 2018 Mar; 13(3):406-413. PubMed ID: 29326307
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease.
Caravaca-Fontán F; Díaz-Encarnación MM; Lucientes L; Cavero T; Cabello V; Ariceta G; Quintana LF; Marco H; Barros X; Ramos N; Rodríguez-Mendiola N; Cruz S; Fernández-Juárez G; Rodríguez A; Pérez de José A; Rabasco C; Rodado R; Fernández L; Pérez Gómez V; Ávila AI; Bravo L; Lumbreras J; Allende N; Sanchez de la Nieta MD; Rodríguez E; Olea T; Melgosa M; Huerta A; Miquel R; Mon C; Fraga G; de Lorenzo A; Draibe J; Cano-Megías M; González F; Shabaka A; López-Rubio ME; Fenollosa MÁ; Martín-Penagos L; Da Silva I; Alonso Titos J; Rodríguez de Córdoba S; Goicoechea de Jorge E; Praga M;
Clin J Am Soc Nephrol; 2020 Sep; 15(9):1287-1298. PubMed ID: 32816888
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive Treatment in C3 Glomerulopathy: Is it Really Effective?
Caliskan Y; Torun ES; Tiryaki TO; Oruc A; Ozluk Y; Akgul SU; Temurhan S; Oztop N; Kilicaslan I; Sever MS
Am J Nephrol; 2017; 46(2):96-107. PubMed ID: 28700996
[TBL] [Abstract][Full Text] [Related]
5. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
6. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial.
Favi E; Spagnoletti G; Salerno MP; Pedroso JA; Romagnoli J; Citterio F
Clin Transplant; 2013; 27(4):E359-67. PubMed ID: 23710603
[TBL] [Abstract][Full Text] [Related]
8. Durable remission of C3 glomerulonephritis with mycophenolate mofetil.
Lioufas N; Finlay M; Barbour T
Nephrology (Carlton); 2017 Feb; 22 Suppl 1():36-39. PubMed ID: 28176473
[TBL] [Abstract][Full Text] [Related]
9. Successful therapy of C3Nef-positive C3 glomerulopathy with plasma therapy and immunosuppression.
Häffner K; Michelfelder S; Pohl M
Pediatr Nephrol; 2015 Nov; 30(11):1951-9. PubMed ID: 25986912
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of 'rescue therapy' with mycophenolate mofetil in resistant primary glomerulonephritis--a multicenter study.
Segarra A; Amoedo ML; Martinez Garcia JM; Pons S; Praga M; Garcia EI; Alonso JC; Gascó JM; Pou L; Piera L
Nephrol Dial Transplant; 2007 May; 22(5):1351-60. PubMed ID: 17311833
[TBL] [Abstract][Full Text] [Related]
12. Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids.
Jones G; Juszczak M; Kingdon E; Harber M; Sweny P; Burns A
Nephrol Dial Transplant; 2004 Dec; 19(12):3160-4. PubMed ID: 15479745
[TBL] [Abstract][Full Text] [Related]
13. Treatment with mycophenolate mofetil attenuates the development of Heymann nephritis.
Luca ME; Paul LC; van Der Wal AM; Bruijn JA; de Heer E
Exp Nephrol; 2000; 8(2):77-83. PubMed ID: 10729746
[TBL] [Abstract][Full Text] [Related]
14. Anti-glomerular basement membrane disease treated with mycophenolate mofetil, corticosteroids, and plasmapheresis.
Mori M; Nwaogwugwu U; Akers GR; McGill RL
Clin Nephrol; 2013 Jul; 80(1):67-71. PubMed ID: 23803597
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Clinical, Laboratory and Treatment Modalities in C3 Glomerulopathy: Single Center Experience.
Yeter HH; Sütiçen E; Korucu B; Helvaci Ö; Özbaş B; Gönül İ; Derici Ü; Arinsoy T; Güz G
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):15-23. PubMed ID: 31605593
[TBL] [Abstract][Full Text] [Related]
16. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil.
Chandrakantan A; Ratanapanichkich P; Said M; Barker CV; Julian BA
Nephrol Dial Transplant; 2005 Jun; 20(6):1214-21. PubMed ID: 15797890
[TBL] [Abstract][Full Text] [Related]
17. Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial.
Guba M; Pratschke J; Hugo C; Krämer BK; Nohr-Westphal C; Brockmann J; Andrassy J; Reinke P; Pressmar K; Hakenberg O; Fischereder M; Pascher A; Illner WD; Banas B; Jauch KW;
Transplantation; 2010 Jul; 90(2):175-83. PubMed ID: 20463641
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
[TBL] [Abstract][Full Text] [Related]
19. [Mycophenolate mofetil in high risk IgA glomerulonephritis].
Frutos MA; López V; Alférez MJ; Aranda P
Nefrologia; 2005; 25(4):387-92. PubMed ID: 16231504
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
